These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 25712526)

  • 1. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
    Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
    Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells.
    Yu Y; Yang L; Zhao M; Zhu S; Kang R; Vernon P; Tang D; Cao L
    Leukemia; 2012 Aug; 26(8):1752-60. PubMed ID: 22395361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy.
    Zou Z; Wu L; Ding H; Wang Y; Zhang Y; Chen X; Chen X; Zhang CY; Zhang Q; Zen K
    J Biol Chem; 2012 Feb; 287(6):4148-56. PubMed ID: 22157765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.
    Tai WT; Shiau CW; Chen HL; Liu CY; Lin CS; Cheng AL; Chen PJ; Chen KF
    Cell Death Dis; 2013 Feb; 4(2):e485. PubMed ID: 23392173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy.
    Xu R; Liu S; Chen H; Lao L
    Oncol Rep; 2016 Mar; 35(3):1757-63. PubMed ID: 26708607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppression of miR-30a/HMGA2-mediated autophagy in osteosarcoma cells impacts chemotherapeutics-induced apoptosis].
    Xia Q; Ni J; Huang J; Pan B; Yan M; Li W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):757-766. PubMed ID: 31413213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells.
    Zhu H; Wu H; Liu X; Li B; Chen Y; Ren X; Liu CG; Yang JM
    Autophagy; 2009 Aug; 5(6):816-23. PubMed ID: 19535919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma.
    Gillissen B; Richter A; Richter A; Preissner R; Schulze-Osthoff K; Essmann F; Daniel PT
    J Biol Chem; 2017 Apr; 292(16):6478-6492. PubMed ID: 28154184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
    Liu S; Gao M; Wang X; Ding S; Lv J; Gao D; Wang Z; Niu Z
    Oncotarget; 2016 Nov; 7(48):79141-79153. PubMed ID: 27816967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer.
    Yang X; Bai F; Xu Y; Chen Y; Chen L
    Cell Physiol Biochem; 2017; 43(3):1126-1139. PubMed ID: 28977798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY; Lam SK; Mak JC; Zheng CY; Ho JC
    Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.
    Sim MY; Huynh H; Go ML; Yuen JSP
    PLoS One; 2017; 12(6):e0178168. PubMed ID: 28582447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells.
    Yuan H; Li AJ; Ma SL; Cui LJ; Wu B; Yin L; Wu MC
    World J Gastroenterol; 2014 May; 20(17):4953-62. PubMed ID: 24833845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy.
    Wang P; Liang J; Li Y; Li J; Yang X; Zhang X; Han S; Li S; Li J
    Neurochem Res; 2014 Jul; 39(7):1279-91. PubMed ID: 24771295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
    Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo.
    Tei H; Miyake H; Fujisawa M
    Hum Cell; 2015 Jul; 28(3):114-21. PubMed ID: 25862630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
    Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells.
    Zhang Q; Si S; Schoen S; Chen J; Jin XB; Wu G
    J Exp Clin Cancer Res; 2013 Dec; 32(1):99. PubMed ID: 24305604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.